CSPC Pharmaceutical Group (HKG:1093) reported an over 139% jump in attributable profit for the first half of 2026 to 6.09 billion yuan from 2.55 billion yuan a year earlier, according to a Thursday Hong Kong bourse filing.

Earnings per share for the six months ended June 30 climbed to 0.5336 yuan from 0.2229 yuan in the prior-year period.

Revenue of the pharma company jumped 40.1% year on year to 18.6 billion yuan from 13.3 billion yuan.

The company declared an interim dividend of HK$0.18 per share, payable on Nov. 10 to shareholders of record on Oct. 26.

Shares of the company jumped nearly 14% in recent trade.